CiclosporinIntervention2 papersPubChem 5284373ChEBI 4031Animals1LatestLancet·19 FebEverolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trialRandomised trial in 503 peoplemTOR inhibitorsPaperClinical Pharmacokinetics·1 JanClinical pharmacokinetics of everolimusReviewmTOR inhibitorsPaperToxicology and Applied Pharmacology·1 JanAttenuation of cadmium-induced liver injury in senescent male fischer 344 rats: role of Kupffer cells and inflammatory cytokinesExperiments in ratsInflammationPaper
Lancet·19 FebEverolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trialRandomised trial in 503 peoplemTOR inhibitorsPaper
Toxicology and Applied Pharmacology·1 JanAttenuation of cadmium-induced liver injury in senescent male fischer 344 rats: role of Kupffer cells and inflammatory cytokinesExperiments in ratsInflammationPaper